Neuroprotective Gene Therapy for Parkinson’s Disease
Journal:
Current Gene Therapy
Volume:
2
Page:
451-483
Author(s):
L. Tenenbaum, A. Chtarto, E. Lehtonen, D. Blum, V. Baekelandt, T. Velu, J. Brotchi and M. Levivier
Modulation of the Peripheral and Central Inflammatory Responses by a-Melanocyte Stimulating Hormone
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
623-628
Author(s):
B. K. Oktar and I. Alican
Nitric Oxide in Atherosclerosis
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
2
Page:
585-593
Author(s):
E. A. Rekka and M. C. Chrysselis
Depressed or Demented: Common CNS Drug Targets? !
Journal:
Current Drug Targets - CNS & Neurological Disorders
Volume:
1
Page:
575-592
Author(s):
Miao-Kun Sun and Daniel L. Alkon
Endogenous Chemical Mediators in Anti-Inflammation and Pro-Resolution
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
177-192
Author(s):
C. N. Serhan
Cerebral Hemorrhage Produced by Thrombolytic and Anti-Thrombotic Agents: A Review
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
273-278
Author(s):
Y. Suzuki, B. Q. Zhao and K. Umemura
New Immunosuppressants in Clinical Trial
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
2
Page:
73-77
Author(s):
Vivian C. McAlister
Pharmacotherapeutic Approach to Prevent or Treat Chronic Allograft Nephropathy
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
2
Page:
79-96
Author(s):
E. M. Scholten, J. W. de Fijter and L. C. Paul
Therapeutic Interventions In Xenotransplantation
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
2
Page:
105-119
Author(s):
C. Knosalla, B. Gollackner, F.J. M.F. Dor and D. K.C. Cooper
Styrene Maleic Acid Neocarzinostatin Treatment for Hepatocellular Carcinoma
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
715-726
Author(s):
Shintaro Abe and Makoto Otsuki